Comprehensive Approach to Peritoneal Mesothelioma Described 

No Comments

Researchers from Columbia University have reported that combined resection, intraperitoneal chemotherapy, and whole abdominal radiation therapy is effective treatment for malignant peritoneal mesothelioma. The details of this study were reported in the February 2008 issue of the American Journal of Clinical Oncology.1
Peritoneal mesothelioma is much less common than pleural mesothelioma, making up less than 20% […]

Upswing in asbestos filings is a turnabout in Madison County 

No Comments

3/20/2008 6:25 PM
By Steve Gonzalez
Asbestos cases filed in Madison County have dropped off in the past few years. But the trend is being challenged.
During a five-day filing period betweem March 13 and March 18, lawyers from five law firms filed 20 asbestos cases, the most in a one-week period in more than two years.
And out […]

Mesothelioma Victim’s dying wish honored 

No Comments

Norrie Ross
February 06, 2008 12:00am

Larger than life: Meg Bentley with an image of Tim Lacone, who has died of an asbestos-related disease.
INVENTOR Tim Lacone knew he was about to die from an asbestos-related disease, but his thoughts were for thousands of Australians yet to fall victim to the lethal particles.
A year to the day […]

Asbestos exposure will kill 300 workers a year: survey 

No Comments

Illness in B.C. from deadly fibres epidemic, union says

Wayne Peppard, 60, executive director of the construction trades council, and a plumber for 37 years, is now being tested for possible disease caused by his lengthy exposure to asbestos. He says many cases of asbestos-related disease go undiagnosed and B.C. is seeing an epidemic.
Ian Smith, Vancouver […]

Radical Decortication/Pleurectomy Best Surgical Approach for N2 Malignant Mesothelioma: Presented at STS 

No Comments

By Ed Susman
FORT LAUDERDALE, FL — February 1, 2008 — Patients who underwent the more extensive treatment of radical decortication/pleurectomy in attempt to cure stage 3 pure epithelial mesothelioma appear to have significantly better outcomes than patients who had less extensive operations, according to a study presented here at the Society of Thoracic Surgeons 44th […]

Minnesotan claims sales rep father suffered mesothelioma 

No Comments

1/23/2008 1:15 AM
By Steve Gonzalez
A Minnesota man filed an asbestos suit against 10 defendant corporations in Madison County Circuit Court Jan. 16, alleging his father died from mesothelioma.
Bruno Zagar claims his father, Anthony, was diagnosed with mesothelioma on Jan. 1, 2004, and died on Dec. 2, 2004.
He claims that during the course of his father’s […]

Par unit buys licensing rights for malignant mesothelioma drug from Alfacell 

No Comments

January 15, 2008: 09:01 AM EST
NEW YORK, Jan. 15, 2008 (Thomson Financial delivered by Newstex) — Par Pharmaceutical Companies Inc.’s (NYSE:PRX) proprietary products division said Tuesday it has acquired the exclusive licensing and commercialization rights to Onconase from Alfacell Corp. (NASDAQ:ACEL)
Onconase is a drug used in the treatment of inoperable malignant mesothelioma currently in Phase […]

Extrapleural Pneumonectomy, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural 

No Comments

Extrapleural Pneumonectomy, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

This study is currently recruiting participants.

Verified by Dana-Farber Cancer Institute, December 2007

[…]

Vinflunine Improves Response and Survival in Mesothelioma 

No Comments

NEW YORK NOV 08, 2007 (Reuters Health) - High-dose vinflunine, a novel microtubule inhibitor, provides encouraging response and survival rates in patients with malignant
pleural mesothelioma, according to a report in the October 20th issue of the Journal of Clinical Oncology.
Although numerous systemic
treatments have been evaluated malignant
pleural mesothelioma, the authors explain, response […]

A new technology for cancer screening listens for the signs of cancer 

No Comments

ACµRay(tm) sensor chip developed by Georgia Tech researchers for early detection of cancer. Credit: AACR
Cancer-sensing devices built as cheaply and efficiently as wristwatches – using many of the same operating principles – could change the way clinicians detect, treat and monitor cancer in patients. Researchers from the Georgia Institute of Technology have created an […]